3. Copp A, Adzick N, Chitty L, Fletcher J, Holmbeck G, Shaw G. Spina bifida. Nature Reviews Disease Primers. 2015;1(1):1-18.
5. Mohd-Zin S, Marwan A, Abou Chaar M, Ahmad-Annuar A, Abdul-Aziz N. Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans. Scientifica. 2017;2017:1-29.
11. Chen S, Zhang Q, Bai B, Ouyang S, Bao Y, Li H et al. MARK2/Par1b Insufficiency Attenuates DVL Gene Transcription via Histone Deacetylation in Lumbosacral Spina Bifida. Molecular Neurobiology. 2016;54(8):6304-6316.
12. Rochtus A, Winand R, Laenen G, Izzi B, Wittevrongel C, Moreau Y et al. Methylome analysis for spina bifida shows SOX18 hypomethylation as risk factor with evidence for a complex (epi)genetic interplay to affect neural tube development. European Journal of Paediatric Neurology. 2017;21:e45-e46.
13. A Common Variant in MTHFD1L is Associated with Increased Risk for Spina Bifida. Journal of Molecular and Clinical Medicine. 2018;1(1):19-22.
14. Lemay P, De Marco P, Emond A, Spiegelman D, Dionne-Laporte A, Laurent S et al. Rare deleterious variants in GRHL3 are associated with human spina bifida. Human Mutation. 2017;38(6):716-724.
15. Othman S, AlOjan A, AlShammari M, Ammar A. Awareness of spina bifida among family of affected child. A cross sectional questionnaire. Saudi Medical Journal. 2019;40(7):727-731.
16. Maged A, Elsherbini M, Ramadan W, Elkomy R, Helal O, Hatem D et al. Periconceptional risk factors of spina bifida among Egyptian population: a case–control study. The Journal of Maternal-Fetal & Neonatal Medicine. 2015;29(14):1-4.
17. Kondo A, Matsuo T, Morota N, Kondo A, Okai I, Fukuda H. Neural tube defects: Risk factors and preventive measures. Congenital Anomalies. 2017;57(5):150-156.
18. Padula A, Yang W, Schultz K, Lurmann F, Hammond S, Shaw G. Genetic variation in biotransformation enzymes, air pollution exposures, and risk of spina bifida. American Journal of Medical Genetics Part A. 2018;176(5):1055-1090.